{
    "accessibility": "Open access",
    "additionDate": "2022-09-17T19:26:36.917114Z",
    "bioagentsCURIE": "bioagents:oncmtr",
    "bioagentsID": "oncmtr",
    "confidence_flag": "agent",
    "cost": "Free of charge",
    "credit": [
        {
            "email": "dimitrios.vitsios@astrazeneca.com",
            "name": "Dimitrios Vitsios",
            "orcidid": "https://orcid.org/0000-0002-8939-5445",
            "typeEntity": "Person"
        },
        {
            "email": "ryan.dhindsa@astrazeneca.com",
            "name": "Ryan S. Dhindsa",
            "orcidid": "https://orcid.org/0000-0002-8965-0813",
            "typeEntity": "Person"
        },
        {
            "email": "slav.petrovski@astrazeneca.com",
            "name": "Slav√© Petrovski",
            "orcidid": "https://orcid.org/0000-0002-1527-961X",
            "typeEntity": "Person"
        },
        {
            "name": "Andrew R. Harper",
            "orcidid": "https://orcid.org/0000-0001-5327-0328"
        }
    ],
    "description": "OncMTR stands for missense tolerance ratio specific for cancer-driving mutations. It is designed to predict cancer-causing somatic mutations. The lower the OncMTR score, the less tolerant the region for cancer-causing somatic mutations. Positions with scores below -0.05 are considered missense intolerant regions.",
    "editPermission": {
        "type": "private"
    },
    "function": [
        {
            "input": [
                {
                    "data": {
                        "term": "Ensembl ID",
                        "uri": "http://edamontology.org/data_2610"
                    }
                },
                {
                    "data": {
                        "term": "Gene name",
                        "uri": "http://edamontology.org/data_2299"
                    }
                }
            ],
            "operation": [
                {
                    "term": "Genotyping",
                    "uri": "http://edamontology.org/operation_3196"
                },
                {
                    "term": "Variant calling",
                    "uri": "http://edamontology.org/operation_3227"
                },
                {
                    "term": "Variant prioritisation",
                    "uri": "http://edamontology.org/operation_3226"
                }
            ]
        }
    ],
    "homepage": "https://astrazeneca-cgr-publications.github.io/OncMTR-Viewer/",
    "lastUpdate": "2022-09-17T19:26:36.919643Z",
    "name": "OncMTR",
    "operatingSystem": [
        "Linux",
        "Mac",
        "Windows"
    ],
    "owner": "Jennifer",
    "publication": [
        {
            "doi": "10.1126/sciadv.abo6371",
            "metadata": {
                "abstract": "Large reference datasets of protein-coding variation in human populations have allowed us to determine which genes and genic subregions are intolerant to germline genetic variation. There is also a growing number of genes implicated in severe Mendelian diseases that overlap with genes implicated in cancer. We hypothesized that cancer-driving mutations might be enriched in genic subregions that are depleted of germline variation relative to somatic variation. We introduce a new metric, OncMTR (oncology missense tolerance ratio), which uses 125,748 exomes in the Genome Aggregation Database (gnomAD) to identify these genic subregions. We demonstrate that OncMTR can significantly predict driver mutations implicated in hematologic malignancies. Divergent OncMTR regions were enriched for cancer-relevant protein domains, and overlaying OncMTR scores on protein structures identified functionally important protein residues. Last, we performed a rare variant, gene-based collapsing analysis on an independent set of 394,694 exomes from the UK Biobank and find that OncMTR markedly improves genetic signals for hematologic malignancies.",
                "authors": [
                    {
                        "name": "Armenia J."
                    },
                    {
                        "name": "Dhindsa R.S."
                    },
                    {
                        "name": "Harper A.R."
                    },
                    {
                        "name": "Hu F."
                    },
                    {
                        "name": "Matelska D."
                    },
                    {
                        "name": "Mitchell J."
                    },
                    {
                        "name": "Petrovski S."
                    },
                    {
                        "name": "Sidders B."
                    },
                    {
                        "name": "Vitsios D."
                    },
                    {
                        "name": "Wang Q."
                    },
                    {
                        "name": "Zou X."
                    }
                ],
                "date": "2022-08-26T00:00:00Z",
                "journal": "Science advances",
                "title": "Cancer-driving mutations are enriched in genic regions intolerant to germline variation"
            },
            "pmcid": "PMC9417173",
            "pmid": "36026442"
        }
    ],
    "agentType": [
        "Web application"
    ],
    "topic": [
        {
            "term": "Biobank",
            "uri": "http://edamontology.org/topic_3337"
        },
        {
            "term": "Exome sequencing",
            "uri": "http://edamontology.org/topic_3676"
        },
        {
            "term": "Genetic variation",
            "uri": "http://edamontology.org/topic_0199"
        },
        {
            "term": "Genomics",
            "uri": "http://edamontology.org/topic_0622"
        },
        {
            "term": "Oncology",
            "uri": "http://edamontology.org/topic_2640"
        }
    ]
}
